Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human NGF ELISA Kit (AC2444)
Cat.#: ASET-1033
Specifications
Description Human NGF ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human NGF concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 4.88 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 75-1200 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1327 Human Rabphilin 3A ELISA Kit (AC2738) Quantitative inquiry ASET-2075 Human PROKR2 ELISA Kit (AC3486) Quantitative inquiry ASET-2099 Mouse Neuroglobin ELISA Kit (AC3510) Quantitative inquiry ASET-1357 Human Amyloid Precursor Protein ELISA Kit (AC2768) Quantitative inquiry ASET-2190 Human KIAA1199 ELISA Kit (AC3601) Quantitative inquiry ASET-1961 Mouse Antidiuretic Hormone ELISA Kit (AC3372) Quantitative inquiry ASET-1006 Mouse SHC ELISA Kit (AC2417) Quantitative inquiry ASET-2053 Monkey Fetuin A ELISA Kit (AC3464) Quantitative inquiry ASET-2516 Mouse alpha B Crystallin ELISA Kit (AC3927) Quantitative inquiry ASET-1164 Human SATB2 ELISA Kit (AC2575) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket